Literature DB >> 25366110

Neuro-oncology: a step towards clinical blood biomarkers of glioblastoma.

Matthias Preusser1.   

Abstract

Glioblastoma is the most common primary brain tumour in adults, but— unlike many other cancers—no blood-based biomarkers are available for differential diagnosis, estimation of prognosis or monitoring of treatment response in glioblastoma. New research has detected three proteins with potential clinical value in the blood of patients with glioblastoma.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25366110     DOI： 10.1038/nrneurol.2014.208

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


  9 in total

1.  Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.

Authors:  T Brommeland; L Rosengren; S Fridlund; R Hennig; V Isaksen
Journal:  Acta Neurol Scand       Date:  2007-12       Impact factor: 3.209

2.  Serum YKL-40 following resection for cerebral glioblastoma.

Authors:  Daniela Bernardi; Andrea Padoan; Andrea Ballin; Mariateresa Sartori; Renzo Manara; Renato Scienza; Mario Plebani; Alessandro Della Puppa
Journal:  J Neurooncol       Date:  2011-11-19       Impact factor: 4.130

Review 3.  Circulating biomarkers of CNS tumors: an update.

Authors:  Aysegül Ilhan-Mutlu; Ludwig Wagner; Matthias Preusser
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

4.  Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.

Authors:  Jaime Gállego Pérez-Larraya; Sophie Paris; Ahmed Idbaih; Caroline Dehais; Florence Laigle-Donadey; Soledad Navarro; Laurent Capelle; Karima Mokhtari; Yannick Marie; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre; Alain Mallet
Journal:  Cancer       Date:  2014-08-19       Impact factor: 6.860

5.  Exploratory investigation of eight circulating plasma markers in brain tumor patients.

Authors:  Aysegul Ilhan-Mutlu; Ludwig Wagner; Georg Widhalm; Adelheid Wöhrer; Sophie Bartsch; Thomas Czech; Harald Heinzl; Fritz Leutmezer; Daniela Prayer; Christine Marosi; Wolfgang Base; Matthias Preusser
Journal:  Neurosurg Rev       Date:  2012-07-05       Impact factor: 3.042

6.  Serum GFAP is a diagnostic marker for glioblastoma multiforme.

Authors:  C S Jung; C Foerch; A Schänzer; A Heck; K H Plate; V Seifert; H Steinmetz; A Raabe; M Sitzer
Journal:  Brain       Date:  2007-11-12       Impact factor: 13.501

Review 7.  IGF binding proteins in cancer: mechanistic and clinical insights.

Authors:  Robert C Baxter
Journal:  Nat Rev Cancer       Date:  2014-04-10       Impact factor: 60.716

Review 8.  Diverse pathological implications of YKL-40: answers may lie in 'outside-in' signaling.

Authors:  Mansi Prakash; Manish Bodas; Divya Prakash; Neelu Nawani; Madhukar Khetmalas; Abul Mandal; Cecilia Eriksson
Journal:  Cell Signal       Date:  2013-04-02       Impact factor: 4.315

9.  Hematogenous dissemination of glioblastoma multiforme.

Authors:  Carolin Müller; Johannes Holtschmidt; Martina Auer; Ellen Heitzer; Katrin Lamszus; Alexander Schulte; Jakob Matschke; Sabine Langer-Freitag; Christin Gasch; Malgorzata Stoupiec; Oliver Mauermann; Sven Peine; Markus Glatzel; Michael R Speicher; Jochen B Geigl; Manfred Westphal; Klaus Pantel; Sabine Riethdorf
Journal:  Sci Transl Med       Date:  2014-07-30       Impact factor: 17.956
  9 in total
  11 in total

1.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

2.  TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin αvβ5-Src-Stat3 signaling.

Authors:  Peng Peng; Hongtao Zhu; Dan Liu; Zirong Chen; Xiaolin Zhang; Zhongyin Guo; Minhai Dong; Lijun Wan; Po Zhang; Guohao Liu; Suojun Zhang; Fangyong Dong; Feng Hu; Fangling Cheng; Shijun Huang; Dongsheng Guo; Bin Zhang; Xingjiang Yu; Feng Wan
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

Review 3.  Renin angiotensin system and its role in biomarkers and treatment in gliomas.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Liliana Gómez-Flores-Ramos; Montserrat Lara-Velazquez; Cordelia Orillac; Juan Luis Gómez-Amador; Talia Wegman-Ostrosky
Journal:  J Neurooncol       Date:  2018-02-16       Impact factor: 4.130

Review 4.  Prospects of immune checkpoint modulators in the treatment of glioblastoma.

Authors:  Matthias Preusser; Michael Lim; David A Hafler; David A Reardon; John H Sampson
Journal:  Nat Rev Neurol       Date:  2015-08-11       Impact factor: 42.937

Review 5.  A Rational Approach to Target the Epidermal Growth Factor Receptor in Glioblastoma.

Authors:  Madan M Kwatra
Journal:  Curr Cancer Drug Targets       Date:  2017       Impact factor: 3.428

6.  Liquid biopsies in patients with diffuse glioma.

Authors:  Myron G Best; Nik Sol; Sebastiaan Zijl; Jaap C Reijneveld; Pieter Wesseling; Thomas Wurdinger
Journal:  Acta Neuropathol       Date:  2015-02-27       Impact factor: 17.088

7.  Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables.

Authors:  Friedrich Erhart; Johanna Buchroithner; René Reitermaier; Katrin Fischhuber; Simone Klingenbrunner; Ido Sloma; Dror Hibsh; Renana Kozol; Sol Efroni; Gerda Ricken; Adelheid Wöhrer; Christine Haberler; Johannes Hainfellner; Günther Krumpl; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus
Journal:  Acta Neuropathol Commun       Date:  2018-12-05       Impact factor: 7.801

Review 8.  Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence.

Authors:  Hayley P Ellis; Mark Greenslade; Ben Powell; Inmaculada Spiteri; Andrea Sottoriva; Kathreena M Kurian
Journal:  Front Oncol       Date:  2015-11-16       Impact factor: 6.244

9.  Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Nancy Reynoso-Noverón; Liliana Gómez-Flores-Ramos; Ernesto Soto-Reyes; Thalía Estefania Sánchez-Correa; Lissania Guerra-Calderas; Clementina Castro-Hernandez; Silvia Vidal-Millán; José Sánchez-Corona; Lucia Taja-Chayeb; Olga Gutiérrez; Bernardo Cacho-Diaz; Rosa Maria Alvarez-Gomez; Juan Luis Gómez-Amador; Patricia Ostrosky-Wegman; Teresa Corona; Luis Alonso Herrera-Montalvo; Talia Wegman-Ostrosky
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

10.  Glial Fibrillary Acidic Protein as Biomarker Indicates Purity and Property of Auricular Chondrocytes.

Authors:  Satoru Nishizawa; Sanshiro Kanazawa; Yuko Fujihara; Yukiyo Asawa; Satoru Nagata; Motohiro Harai; Atsuhiko Hikita; Tsuyoshi Takato; Kazuto Hoshi
Journal:  Biores Open Access       Date:  2020-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.